Azvalor Value Selection SICAV is an actively managed investment vehicle that follows the Value Investment philosophy or “value investing”, based on long-term investment in companies with understandable business models, strong management, aligned ownership, and which are undervalued by the market—with significant upside potential. The fund is managed by an experienced investment team applying the “Azvalor Method”, led by the Co-directors of Investment, who each have over 25 years of experience.
Azvalor Value Selection is listed on the BME MTF Equity market and seeks to maintain exposure to equities listed on regulated markets in OECD countries. The portfolio is composed of companies listed in developed markets, including Spanish and Portuguese equities, with the majority of exposure in European and US companies, selected on a bottom-up basis and independently of their weighting in benchmark indices. The portfolio is typically concentrated, with a significant allocation to its top 15 holdings. Cash exposure may not exceed 25% of the portfolio and is managed actively depending on market opportunities and the valuation of portfolio companies. Currently, approximately 80% of assets are invested in the International Portfolio and 20% in the Iberian Portfolio (these allocations may vary at the discretion of the management team based on investment opportunities).
In order to preserve the fund’s long-term upside potential—maximising target value while minimising risk—a disciplined portfolio rotation process is applied, reallocating capital towards the most attractive investment opportunities at any given time.
The fund’s objective is to preserve the purchasing power of capital by outperforming inflation and delivering returns in excess of the main equity indices of developed markets.
Azvalor Value Selection SICAV is suitable for investors without short-term liquidity needs and with an investment horizon of more than five years.
Distributors
Shares in Azvalor Value Selection SICAV may be acquired through any authorised securities firm. Please consult your usual financial intermediary or contact our Investor Relations team for further information.
